Fenretinide (island Pharmaceuticals)

N/A

Report date: 2025/05/12 16:57:50

Base Information

Drug NameFenretinide (island Pharmaceuticals)
Drug Alias NameIsla-101
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionViral proteins inhibitorsRetinoic acid receptor beta agonistsRetinoic acid receptor gamma inverse agonists +[4] 
TargetsViral proteinsRetinoic acid receptor betaRetinoic acid receptor gamma
Therapy Area/IndicationsDengue
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMonash UniversityIsland Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIsland Pharmaceuticals LtdMonash University
Inactive CompaniesN/A
Active IndicationsDengue
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A